Top compounds associated with response to RAB40A


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.1 0.001
mRNA ouabain CTRPv2 pan-cancer AAC 0.11 0.002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Pyrimethamine GDSC1000 pan-cancer AAC -0.15 0.005
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.099 0.006
Download CSV